Home LiteratureArticle Details
PMID: 17298183 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system.

PLoS biology ·Vol. 5 ·No. 3 ·2007-03-00 ·Pages e39

Kramer ER, Aron L, Ramakers GM, Seitz S, Zhuang X, Beyer K, Smidt MP, Klein R

Abstract

Support of ageing neurons by endogenous neurotrophic factors such as glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF) may determine whether the neurons resist or succumb to neurodegeneration. GDNF has been tested in clinical trials for the treatment of Parkinson disease (PD), a common neurodegenerative disorder characterized by the loss of midbrain dopaminergic (DA) neurons. BDNF modulates nigrostriatal functions and rescues DA neurons in PD animal models. The physiological roles of GDNF and BDNF signaling in the adult nigrostriatal DA system are unknown. We generated mice with regionally selective ablations of the genes encoding the receptors for GDNF (Ret) and BDNF (TrkB). We find that Ret, but not TrkB, ablation causes progressive and adult-onset loss of DA neurons specifically in the substantia nigra pars compacta, degeneration of DA nerve terminals in striatum, and pronounced glial activation. These findings establish Ret as a critical regulator of long-term maintenance of the nigrostriatal DA system and suggest conditional Ret mutants as useful tools for gaining insights into the molecular mechanisms involved in the development of PD.

MeSH Terms
Animals Brain-Derived Neurotrophic Factor/metabolism Corpus Striatum/metabolism,pathology Glial Cell Line-Derived Neurotrophic Factor/metabolism Glial Cell Line-Derived Neurotrophic Factor Receptors/genetics Immunohistochemistry Mice Mice, Inbred C57BL Mice, Transgenic Proto-Oncogene Proteins c-ret/metabolism Receptor, trkB/genetics Signal Transduction Substantia Nigra/metabolism,pathology
Chemicals
Brain-Derived Neurotrophic Factor Glial Cell Line-Derived Neurotrophic Factor Glial Cell Line-Derived Neurotrophic Factor Receptors Proto-Oncogene Proteins c-ret Receptor, trkB Ret protein, mouse
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Kramer Edgar R
Department of Molecular Neurobiology, Max-Planck Institute of Neurobiology, Martinsried, Germany. ekramer@neuro.mpg.de
Aron Liviu
Ramakers Geert M J
Seitz Sabine
Zhuang Xiaoxi
Beyer Klaus
Smidt Marten P
Klein Rüdiger
References (59)
59 references, click to expand
  1. Targeting programmed cell death in neurodegenerative diseases.
    Nat Rev Neurosci. 2003 May;4(5):365-75 PMID: 12728264
  2. Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of alpha-synuclein in the substantia nigra.
    FASEB J. 2005 Oct;19(12):1740-2 PMID: 16037097
  3. Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo.
    J Neurosci. 2003 Jun 15;23(12):5141-8 PMID: 12832538
  4. Novel functions and signalling pathways for GDNF.
    J Cell Sci. 2003 Oct 1;116(Pt 19):3855-62 PMID: 12953054
  5. Parkinson's disease: mechanisms and models.
    Neuron. 2003 Sep 11;39(6):889-909 PMID: 12971891
  6. Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3.
    Development. 2004 Mar;131(5):1145-55 PMID: 14973278
  7. Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets.
    J Neurosci. 2004 Mar 24;24(12):3136-46 PMID: 15044553
  8. Induction of CRMP-2 by GDNF and analysis of the CRMP-2 promoter region.
    Biochem Biophys Res Commun. 2004 Jul 16;320(1):108-15 PMID: 15207709
  9. TrkB regulates neocortex formation through the Shc/PLCgamma-mediated control of neuronal migration.
    EMBO J. 2004 Oct 1;23(19):3803-14 PMID: 15372074
  10. Factors promoting survival of mesencephalic dopaminergic neurons.
    Cell Tissue Res. 2004 Oct;318(1):73-80 PMID: 15300492
  11. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation.
    Cell Tissue Res. 2004 Oct;318(1):149-61 PMID: 15338271
  12. Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro.
    J Neurosci. 1993 Feb;13(2):455-66 PMID: 7678855
  13. Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death.
    Cell. 1993 Oct 8;75(1):113-22 PMID: 8402890
  14. Mice lacking brain-derived neurotrophic factor develop with sensory deficits.
    Nature. 1994 Mar 10;368(6467):147-50 PMID: 8139657
  15. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.
    J Comp Neurol. 1994 Apr 15;342(3):321-34 PMID: 7912699
  16. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease.
    J Neurosci. 1995 Dec;15(12):7810-20 PMID: 8613721
  17. Profound neuronal plasticity in response to inactivation of the dopamine transporter.
    Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):4029-34 PMID: 9520487
  18. Mutation analysis of the glial cell line-derived neurotrophic factor gene in Parkinson's disease.
    Exp Neurol. 1998 Aug;152(2):307-9 PMID: 9710530
  19. Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Immunopharmacology. 1998 Jun;39(3):167-80 PMID: 9754903
  20. Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study.
    J Comp Neurol. 1999 Jan 18;403(3):295-308 PMID: 9886032
  21. Generalized lacZ expression with the ROSA26 Cre reporter strain.
    Nat Genet. 1999 Jan;21(1):70-1 PMID: 9916792
  22. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade.
    Neuron. 1999 Jul;23(3):435-47 PMID: 10433257
  23. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.
    Nat Genet. 1999 Sep;23(1):99-103 PMID: 10471508
  24. Essential role for TrkB receptors in hippocampus-mediated learning.
    Neuron. 1999 Oct;24(2):401-14 PMID: 10571233
  25. Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons.
    J Neurosci. 2000 May 1;20(9):3182-90 PMID: 10777782
  26. The selective vulnerability of striatopallidal neurons.
    Prog Neurobiol. 1999 Dec;59(6):691-719 PMID: 10845758
  27. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease.
    Prog Neurobiol. 2001 Jan;63(1):71-124 PMID: 11040419
  28. Molecular and cellular alterations in the Pitx3-deficient midbrain dopaminergic system.
    Mol Cell Neurosci. 2005 Nov;30(3):352-63 PMID: 16140547
  29. K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons.
    Nat Neurosci. 2005 Dec;8(12):1742-51 PMID: 16299504
  30. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models.
    Nat Neurosci. 2006 Feb;9(2):251-9 PMID: 16415865
  31. Expanding insights of mitochondrial dysfunction in Parkinson's disease.
    Nat Rev Neurosci. 2006 Mar;7(3):207-19 PMID: 16495942
  32. Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
    Ann Neurol. 2006 Mar;59(3):459-66 PMID: 16429411
  33. Genetics of Parkinson disease: paradigm shifts and future prospects.
    Nat Rev Genet. 2006 Apr;7(4):306-18 PMID: 16543934
  34. Continuing trials of GDNF in Parkinson's disease.
    Lancet Neurol. 2006 Apr;5(4):285-6 PMID: 16545740
  35. Ageing and neuronal vulnerability.
    Nat Rev Neurosci. 2006 Apr;7(4):278-94 PMID: 16552414
  36. Cooperation between GDNF/Ret and ephrinA/EphA4 signals for motor-axon pathway selection in the limb.
    Neuron. 2006 Apr 6;50(1):35-47 PMID: 16600854
  37. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
    Neurobiol Dis. 2006 Sep;23(3):522-32 PMID: 16806952
  38. Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice.
    Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15242-7 PMID: 17015829
  39. Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion.
    Brain Res. 2001 Feb 9;891(1-2):228-35 PMID: 11164827
  40. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.
    Nature. 2001 May 3;411(6833):86-9 PMID: 11333982
  41. GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons.
    Nat Neurosci. 2001 Nov;4(11):1071-8 PMID: 11593232
  42. The GDNF family: signalling, biological functions and therapeutic value.
    Nat Rev Neurosci. 2002 May;3(5):383-94 PMID: 11988777
  43. CRMP-2 binds to tubulin heterodimers to promote microtubule assembly.
    Nat Cell Biol. 2002 Aug;4(8):583-91 PMID: 12134159
  44. Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies.
    J Clin Invest. 2002 Nov;110(10):1429-39 PMID: 12438441
  45. Pathogenic role of glial cells in Parkinson's disease.
    Mov Disord. 2003 Feb;18(2):121-9 PMID: 12539204
  46. TGF-betas and their roles in the regulation of neuron survival.
    Adv Exp Med Biol. 2002;513:353-74 PMID: 12575828
  47. Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys.
    J Neurosci. 2003 Mar 1;23(5):1974-80 PMID: 12629203
  48. Neuroinflammatory processes in Parkinson's disease.
    Ann Neurol. 2003;53 Suppl 3:S49-58; discussion S58-60 PMID: 12666098
  49. In vivo gene delivery of glial cell line--derived neurotrophic factor for Parkinson's disease.
    Ann Neurol. 2003;53 Suppl 3:S120-32; discussion S132-4 PMID: 12666104
  50. Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.
    Trends Neurosci. 2003 Apr;26(4):215-21 PMID: 12689773
  51. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.
    Nat Med. 2003 May;9(5):589-95 PMID: 12669033
  52. Glial responses to synaptic damage and plasticity.
    J Neurosci Res. 1999 Oct 1;58(1):33-41 PMID: 10491570
  53. Neurodegenerative alterations in the nigrostriatal system of trkB hypomorphic mice.
    Exp Neurol. 2004 Dec;190(2):337-46 PMID: 15530873
  54. Targeted gene expression in dopamine and serotonin neurons of the mouse brain.
    J Neurosci Methods. 2005 Apr 15;143(1):27-32 PMID: 15763133
  55. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells.
    Eur J Neurosci. 2005 Apr;21(7):1815-27 PMID: 15869477
  56. Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta.
    J Neurosci. 2005 Jun 29;25(26):6251-9 PMID: 15987955
  57. Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain.
    Nat Med. 2005 Jul;11(7):703-4 PMID: 16015352
  58. Nosology of Parkinson's disease: looking for the way out of a quagmire.
    Neuron. 2005 Aug 18;47(4):479-82 PMID: 16102530
  59. MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons.
    J Mol Neurosci. 2003 Apr;20(2):173-88 PMID: 12794311
Article Info
Journal
PLoS biology
Abbr.
PLoS Biol
ISSN
1545-7885
Published
2007-03-00
Pages
e39
Language
English
Region
United States
NLM ID
101183755
PMCID
PMC1808500
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com